Sunrise Consultant Company

Sunrise Research Office

Clear perspective for complex talent decisions

Source-led briefings prepared by Priya Nanduri for employers and professionals in this market.

Healthcare operations leaders reviewing hospital and ambulatory performance data during a transformation planning session

healthcare consulting talent

Healthcare Operations Talent for a Changing Care Model

Rising demand for care, tighter operating economics and payment reform are changing what employers need from healthcare operations consultants in the US.

Read briefing →
Life sciences project leaders mapping staffing needs to regulatory, research and delivery milestones

life sciences consultants

Building Life Sciences Project Teams Around Milestones

US life sciences programs do not staff evenly from kickoff to approval. They expand and tighten around funding events, technical handoffs and FDA-facing deadlines, which makes milestone-based team design more practical than static headcount planning.

Read briefing →
Healthcare and life sciences leaders reviewing regulatory workload and staffing plans with specialist consultants

regulatory consultants

When Regulatory Affairs Capacity Becomes Critical

FDA’s own planning model ties staffing to forecast workload, review timelines, and role mix. For healthcare and life sciences employers, that makes regulatory affairs capacity a planning discipline—not just a hiring count.

Read briefing →
Healthcare transformation leaders reviewing PMO governance, interoperability priorities and cross-functional program plans

PMO consultants

Choosing Leadership for a Healthcare Transformation PMO

Healthcare transformation PMOs need more than project control. The strongest U.S. evidence points to leaders who can unify clinical operations, interoperability, governance, privacy, cybersecurity and measurable change.

Read briefing →
Healthcare market access professionals reviewing payer policy, evidence strategy and reimbursement data

health economics recruitment

Market Access Skills for Evidence-Heavy Decisions

US market access teams increasingly need talent that can connect reimbursement policy, HEOR, real-world evidence and patient-centered insights to launch and lifecycle decisions.

Read briefing →